Drug
Modzatinib
Modzatinib: highest development phase Phase 2, developed by Aclaris Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Aclaris Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Modzatinib NCT07935590 | Phase 2 | Lichen Planus |
Latest
No recent events.
Follow Modzatinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.